Form 8-K - Current report:
SEC Accession No. 0001390478-19-000061
Filing Date
2019-11-25
Accepted
2019-11-25 16:14:18
Documents
1
Period of Report
2019-11-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sls-20191125x8xk.htm 8-K 38629
  Complete submission text file 0001390478-19-000061.txt   39990
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 191246285
SIC: 2834 Pharmaceutical Preparations